QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 KATHERINE: Trastuzumab emtansine vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer 会议论文 作者:  Mamounas, Eleftherios P.;  Geyer, Charles E., Jr.;  Huang, Chiun-Sheng;  Mano, Max S.;  Loibl, Sibylle 收藏  |  浏览/下载：21/0  |  提交时间：2019/12/05 Pooled analysis of WHO Surgical Safety Checklist use and mortality after emergency laparotomy 期刊论文 BRITISH JOURNAL OF SURGERY, 2019, 卷号: 106, 期号: 2 作者:  Thomas, Hannah S.;  Weiser, Thomas G.;  Drake, Thomas M.;  Knight, Stephen R.;  Fairfield, Cameron 收藏  |  浏览/下载：138/0  |  提交时间：2019/12/05 Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+advanced breast cancer: BOLERO-1 会议论文 作者:  Hurvitz, Sara A.;  Andre, Fabrice;  Jiang, Zefei;  Shao, Zhimin;  Neciosup, Silvia P. 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/19 Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial 期刊论文 LANCET ONCOLOGY, 2015, 卷号: 16, 期号: 7 作者:  Hurvitz, Sara A.;  Andre, Fabrice;  Jiang, Zefei;  Shao, Zhimin;  Mano, Max S. 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19